325 related articles for article (PubMed ID: 34012227)
1. Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays.
Benitez-Del-Castillo JM; Soria J; Acera A; Muñoz AM; Rodríguez S; Suárez T
Mol Vis; 2021; 27():243-261. PubMed ID: 34012227
[TBL] [Abstract][Full Text] [Related]
2. Changes in tear biomarker levels in keratoconus after corneal collagen crosslinking.
Recalde JI; Duran JA; Rodriguez-Agirretxe I; Soria J; Sanchez-Tena MA; Pereiro X; Suarez T; Acera A
Mol Vis; 2019; 25():12-21. PubMed ID: 30804658
[TBL] [Abstract][Full Text] [Related]
3. Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation.
Soria J; Acera A; Merayo-LLoves J; Durán JA; González N; Rodriguez S; Bistolas N; Schumacher S; Bier FF; Peter H; Stöcklein W; Suárez T
Sci Rep; 2017 Dec; 7(1):17478. PubMed ID: 29234088
[TBL] [Abstract][Full Text] [Related]
4. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction.
Soria J; Durán JA; Etxebarria J; Merayo J; González N; Reigada R; García I; Acera A; Suárez T
J Proteomics; 2013 Jan; 78():94-112. PubMed ID: 23201116
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
[TBL] [Abstract][Full Text] [Related]
6. Human Tear Serotonin Levels Correlate with Symptoms and Signs of Dry Eye.
Chhadva P; Lee T; Sarantopoulos CD; Hackam AS; McClellan AL; Felix ER; Levitt RC; Galor A
Ophthalmology; 2015 Aug; 122(8):1675-80. PubMed ID: 25983214
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Messmer EM; von Lindenfels V; Garbe A; Kampik A
Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the IL-33/ST2 pathway in dry eye.
Wang S; Zhang H
Mol Vis; 2019; 25():583-592. PubMed ID: 31673224
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Dry Eye Workshop Dry Eye Severity Grading System With Tear Meniscus Measurement by Optical Coherence Tomography and Tear Osmolarity.
Tukenmez-Dikmen N; Yildiz EH; Imamoglu S; Turan-Vural E; Sevim MS
Eye Contact Lens; 2016 May; 42(3):153-7. PubMed ID: 26067398
[TBL] [Abstract][Full Text] [Related]
11. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
Versura P; Profazio V; Campos EC
Curr Eye Res; 2010 Jul; 35(7):553-64. PubMed ID: 20597641
[TBL] [Abstract][Full Text] [Related]
12. A novel and innovative paper-based analytical device for assessing tear lactoferrin of dry eye patients.
Sonobe H; Ogawa Y; Yamada K; Shimizu E; Uchino Y; Kamoi M; Saijo Y; Yamane M; Citterio D; Suzuki K; Tsubota K
Ocul Surf; 2019 Jan; 17(1):160-166. PubMed ID: 30399438
[TBL] [Abstract][Full Text] [Related]
13. Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Nondiabetes With Dry Eye.
Liu R; Ma B; Gao Y; Ma B; Liu Y; Qi H
Am J Ophthalmol; 2019 Apr; 200():10-15. PubMed ID: 30552892
[TBL] [Abstract][Full Text] [Related]
14. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
15. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
Zhao CS; Chen Y; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
[TBL] [Abstract][Full Text] [Related]
16. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
17. Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease.
Choi W; Lian C; Ying L; Kim GE; You IC; Park SH; Yoon KC
Curr Eye Res; 2016 Sep; 41(9):1143-9. PubMed ID: 26731289
[TBL] [Abstract][Full Text] [Related]
18. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
[TBL] [Abstract][Full Text] [Related]
19. Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study.
Guo M; Diaz GM; Yu Y; Patel CA; Farrar JT; Asbell PA; Ying GS;
Ocul Surf; 2024 Apr; 32():112-119. PubMed ID: 38307463
[TBL] [Abstract][Full Text] [Related]
20. Tear osmolarity as a biomarker for dry eye disease severity.
Suzuki M; Massingale ML; Ye F; Godbold J; Elfassy T; Vallabhajosyula M; Asbell PA
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4557-61. PubMed ID: 20393114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
